Vanguard Group
FSTX

Vanguard Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-292,664
Closed -$1.85M 4608
2022
Q4
$1.85M Sell
292,664
-19,944
-6% -$126K ﹤0.01% 3685
2022
Q3
$1.6M Sell
312,608
-576,645
-65% -$2.95M ﹤0.01% 3843
2022
Q2
$5.57M Buy
889,253
+290,816
+49% +$1.82M ﹤0.01% 3326
2022
Q1
$2.12M Sell
598,437
-149,263
-20% -$530K ﹤0.01% 3931
2021
Q4
$3.75M Buy
747,700
+3,077
+0.4% +$15.4K ﹤0.01% 3772
2021
Q3
$5.45M Sell
744,623
-28,592
-4% -$209K ﹤0.01% 3601
2021
Q2
$6.64M Buy
773,215
+244,726
+46% +$2.1M ﹤0.01% 3429
2021
Q1
$5.72M Buy
528,489
+140,441
+36% +$1.52M ﹤0.01% 3458
2020
Q4
$3.83M Sell
388,048
-36,741
-9% -$363K ﹤0.01% 3477
2020
Q3
$569K Sell
424,789
-16,508
-4% -$22.1K ﹤0.01% 3790
2020
Q2
$649K Sell
441,297
-7,227
-2% -$10.6K ﹤0.01% 3708
2020
Q1
$417K Hold
448,524
﹤0.01% 3708
2019
Q4
$709K Hold
448,524
﹤0.01% 3719
2019
Q3
$1.57M Sell
448,524
-55,903
-11% -$196K ﹤0.01% 3528
2019
Q2
$1.86M Sell
504,427
-49,024
-9% -$181K ﹤0.01% 3495
2019
Q1
$5.81M Buy
553,451
+332
+0.1% +$3.48K ﹤0.01% 3084
2018
Q4
$5.75M Buy
553,119
+3,933
+0.7% +$40.9K ﹤0.01% 3023
2018
Q3
$6.62M Buy
549,186
+141,730
+35% +$1.71M ﹤0.01% 3130
2018
Q2
$4.83M Buy
407,456
+46,643
+13% +$553K ﹤0.01% 3226
2018
Q1
$5.55M Buy
360,813
+89,696
+33% +$1.38M ﹤0.01% 3099
2017
Q4
$3.65M Buy
271,117
+79,126
+41% +$1.06M ﹤0.01% 3248
2017
Q3
$3.23M Buy
191,991
+133,386
+228% +$2.25M ﹤0.01% 3267
2017
Q2
$794K Buy
+58,605
New +$794K ﹤0.01% 3623